ClinicalTrials.Veeva

Menu

Applying Artificial Intelligence to Identify Subphenotypes of Acute Kidney Injury in Mexican Patients With Severe COVID-19 (IA-COVAKI)

N

National Institute of Respiratory Diseases (INER)

Status

Completed

Conditions

COVID-19
Acute Kidney Injury

Treatments

Diagnostic Test: clusters

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The goal of this observational study was to identify subphenotypes of acute kidney injury patients with COVID-19, and the investigators analyzed their impact on mortality. The study included demographic and clinical variables of the participants. The implementation of Machine Learning algorithms and Artificial Intelligence methods are used, and some specific implementations were designed for the analysis, where each group was characterized by traditional statistical methods.

Enrollment

2,934 patients

Sex

All

Ages

15+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients older than 15 years old, hospitalized, and with severe acute respiratory syndrome (SARS-CoV-2) positive confirmation.

Exclusion criteria

  • Patients who did not have at least 1 creatinine measurement.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems